Assessment of drug therapy in Parkinsonism.
D006801:Humans; D009662:Nortropanes; D009966:Orphenadrine; D010276:Parasympatholytics; D010300:Parkinson Disease; D020734:Parkinsonian Disorders
D009662:Nortropanes; D010276:Parasympatholytics; D009966:Orphenadrine
NORTROPANES; ORPHENADRINE; PARALYSIS AGITANS; PARASYMPATHOLYTICS